Research Topic · Peer-Reviewed

Cognitive Impairment

Cognitive impairment is a measurable decline in one or more cognitive domains, such as memory, attention, language, executive function, or visuospatial ability, relative to a prior level of performance. It spans a continuum from mild cognitive impairment, in which deficits exceed expected age-related change but do n…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 27× across the literature 🔖 ISSN 2470-5020 🗓 Reviewed July 2026

Overview

Cognitive impairment is a measurable decline in one or more cognitive domains, such as memory, attention, language, executive function, or visuospatial ability, relative to a prior level of performance. It spans a continuum from mild cognitive impairment, in which deficits exceed expected age-related change but do not substantially compromise independence, to dementia, in which cognitive loss interferes with daily function. It arises from diverse causes including neurodegenerative disease such as Alzheimer's disease, cerebrovascular disease and stroke, traumatic brain injury, multiple sclerosis, and metabolic, infectious, and psychiatric contributors, with depression an important and sometimes reversible factor. Mechanisms include synaptic and neuronal loss, disrupted functional connectivity, neuroinflammation, and structural changes such as medial temporal lobe atrophy. Evaluation relies on neuropsychological testing, neuroimaging, and biomarkers, while management addresses underlying causes and applies cognitive stimulation, behavioral, assistive-technology, and pharmacological strategies. Research in this area examines participation in cognitive stimulation training for mild cognitive impairment, the relationship between cortisol, depression, and medial temporal lobe atrophy in mild cognitive impairment and Alzheimer's disease, assistive technology and cognitive-behavioral programs in Alzheimer's disease, functional connectivity in dementia, and the cognitive consequences of systemic illness. The journal publishes peer-reviewed research on the causes, assessment, progression, and treatment of cognitive impairment.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2019

Neuroscience Theories, Hypothesis and Approaches to ASD Physiopathology. A Review

OJ CastejónCorresponding author
Instituto de Investigaciones Biológicas “Drs. Orlando Castejón and Haydee Viloria de Castejón” e Instituto de Neurociencias Clínicas, Fundación Castejón, San Rafael Clinical Home. Maracaibo. Venezuela.
Neurological Research and Therapy Cited by 2 doi:10.14302/issn.2470-5020.jnrt-19-2974
2016

Depression and Dementia

Volicer LadislavCorresponding author
School of Aging Studies, University of South Florida, Tampa, FL, USA
Exact topic Depression And Therapy Cited by 2 doi:10.14302/issn.2476-1710.jdt-16-1260
2021

Impact of COVID-19 on Cognitive and Way to Resolve

Azizur Rahman MohammadCorresponding author
Department of Biochemistry and Molecular Biology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-21-4007

How this research is being cited

The 12 articles above have been cited 27 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cognitive Impairment, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Neurological Research and Therapy (ISSN 2470-5020).

Journal editorial board
Ian J Martins · Australia Giuseppe Lanza · Italy Ion Codreanu · United States

This page summarises published research for orientation; it is not medical or professional advice.